Last reviewed · How we verify
Medical weight loss
Medical weight loss refers to physician-supervised weight management programs that typically combine behavioral modification, dietary intervention, and pharmacological agents to reduce body weight.
Medical weight loss programs typically combine behavioral interventions, dietary modifications, and sometimes pharmacotherapy to reduce body weight and improve metabolic health. Used for Obesity management and weight reduction.
At a glance
| Generic name | Medical weight loss |
|---|---|
| Sponsor | University of California, Los Angeles |
| Modality | Small molecule |
| Therapeutic area | Obesity / Metabolic Disease |
| Phase | FDA-approved |
Mechanism of action
Medical weight loss is not a single drug but rather a clinical approach to obesity management. Programs may incorporate FDA-approved weight loss medications (such as GLP-1 receptor agonists, phentermine, or orlistat), structured diet plans, exercise protocols, and behavioral counseling. The mechanisms vary depending on the specific medications and interventions used within the program.
Approved indications
- Obesity management and weight reduction
Common side effects
Key clinical trials
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer (PHASE2)
- Exercise for the Treatment of Cancer-Related Sarcopenia (NA)
- Dyad Plus Effectiveness/Feasibility (NA)
- Preoperative Weight Loss for Open Abdominal Wall Reconstruction (NA)
- Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment (NA)
- Early Detection Initiative for Pancreatic Cancer (NA)
- Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
- Community Health Worker Coaching to Reduce Cardiovascular Risk Among Women After a Hypertensive Disorder of Pregnancy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Medical weight loss CI brief — competitive landscape report
- Medical weight loss updates RSS · CI watch RSS
- University of California, Los Angeles portfolio CI